search
Back to results

IL-32 Levels in Patients With Chronic Periodontitis

Primary Purpose

Periodontitis

Status
Completed
Phase
Phase 1
Locations
Study Type
Interventional
Intervention
nonsurgical periodontal treatment
Gingival crevicular fluid and saliva collection
Sponsored by
Bulent Ecevit University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Periodontitis focused on measuring Interleukin-32, periodontitis

Eligibility Criteria

35 Years - 55 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • all subjects in the study were possess of at least 20 teeth excluding third molars.

Exclusion Criteria:

  • agressive periodontitis,
  • periapical pathologies,
  • excessive forces including mechanical forces caused by orthodontic forces and occlusal forces;
  • presence of systemic diseases;
  • administration of non-steroidal and anti-inflammatory drugs or antibiotic therapies within the previous 6 months;
  • need for antibiotic prophylaxis for dental treatment and having received non-surgical periodontal treatment within the past 6 months or surgical periodontal treatment within the past 12 months;
  • allergy or sensitivity to any drug,
  • pregnancy,
  • lactation, and
  • current and former use of tobacco.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Placebo Comparator

    Arm Label

    chronic periodontitis patients

    periodontally healthy controls

    Arm Description

    gingival crevicular fluid and saliva collecion were taken before and after nonsurgical periodontal treatment

    gingival crevicular fluid and saliva collection were taken at baseline after oral hygiene instructions

    Outcomes

    Primary Outcome Measures

    Biochemical parameters (IL-32, IL-10 and THF-alpha)
    The changes in levels of IL-32 after periodontal treatment determined by ELISA. The changes in levels of IL-32 were analyzed to determine diagnostic and prognostic potential as a biomarker of periodontitis.

    Secondary Outcome Measures

    Probing pocket depth
    The changes in probing pocket depth after periodontal treatment.Probing pocket depth was measured for determining severity of disease and clinic outcome.
    Probing pocket depth and clinical attachment level
    The changes in clinical attachment level after periodontal treatment. The probing depth and the distance from the gingival margin to the cemento-enamel junction are used to measurement of clinical attachment level. Clinical attachment level was measured for determining severity of disease and clinic outcome.
    Gingival index
    The changes in gingival index after periodontal treatment. Gingival index was recorded for classifying and evaluating (coronally) gingival inflammation.
    Plaque index
    The changes in plaque index after periodontal treatment. Plaque index was recorded for determining and classifying oral hygiene status.
    Bleeding on probing
    The changes in bleeding on probing after periodontal treatment. Bleeding on probing was recorded for classifying and evaluating (apically) gingival inflammation.

    Full Information

    First Posted
    December 10, 2015
    Last Updated
    December 16, 2015
    Sponsor
    Bulent Ecevit University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02632981
    Brief Title
    IL-32 Levels in Patients With Chronic Periodontitis
    Official Title
    IL-32 Levels in Gingival Crevicular Fluid and Saliva of Patients With Chronic Periodontitis After Periodontal Treatment.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2015
    Overall Recruitment Status
    Completed
    Study Start Date
    July 2014 (undefined)
    Primary Completion Date
    May 2015 (Actual)
    Study Completion Date
    July 2015 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Bulent Ecevit University

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Interleukin-32 (IL-32) is a recently described cytokine that is a strong inducer of pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α. A previous report have reported that Porphyromonas gingivalis-derived LPS significantly up-regulated IL-32 expression compared with the unstimulated cells in monocytes (THP-1 cells). They suggested that IL-32 may contribute to the pathogenesis of periodontal disease. In the present study the investigators hypothesized that IL-32 levels may increase in the gingival crevicular fluid (GCF) and saliva of patients with chronic periodontitis compared with healthy controls and these levels may decrease together with treatment.
    Detailed Description
    The purpose of this study was to investigate IL-32 levels in the GCF and saliva of patients with chronic periodontitis and to evaluate changes after nonsurgical periodontal therapy. Twenty-seven CP and 27 periodontally healthy controls were enrolled in this study. Periodontitis patients received nonsurgical periodontal treatment. GCF and saliva sampling and clinical periodontal parameters were assessed before and a month after treatment. IL-32, IL-10 and TNF-α levels in GCF and saliva were measured by enzyme-linked immunosorbent assay. Unstimulated salivary samples were collected using standard techniques. About 2 mL whole saliva was collected in disposable tubes and centrifuged immediately to remove cell debris (10,000 g x 10 minutes). The supernatants (50µL each) were stored at -40C until analyzed. GCF samples were collected from a mesio-buccal and disto-palatal site on each tooth. In the CP group, the samples were obtained from patients at areas with ≥5 mm CAL, ≥6 mm PD and ≥30% bone loss. In the healthy group, GCF samples were collected from teeth exhibiting PD<3 mm without CAL and BOP. The area was isolated with cotton rolls, saliva contamination elimination was ensured, and it was slightly air dried. GCF was sampled with paper strips. Paper strips were placed into the crevice until mild resistance was felt (intracrevicular method) and left in the position for 30 seconds. Strips contaminated with blood or saliva were discarded. Each sampled strip was placed into a 400µl eppendorf centrifuge tube and stored at -40C until analyzed.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Periodontitis
    Keywords
    Interleukin-32, periodontitis

    7. Study Design

    Primary Purpose
    Diagnostic
    Study Phase
    Phase 1
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare ProviderInvestigatorOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    54 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    chronic periodontitis patients
    Arm Type
    Active Comparator
    Arm Description
    gingival crevicular fluid and saliva collecion were taken before and after nonsurgical periodontal treatment
    Arm Title
    periodontally healthy controls
    Arm Type
    Placebo Comparator
    Arm Description
    gingival crevicular fluid and saliva collection were taken at baseline after oral hygiene instructions
    Intervention Type
    Other
    Intervention Name(s)
    nonsurgical periodontal treatment
    Other Intervention Name(s)
    chronic periodontitis patients
    Intervention Description
    Scaling and root planning under local anaesthesia, in a total of four clinical visits Oral hygiene instructions including the modified Bass technique, regular toothpaste, and an appropriate interdental cleaning device with dental floss and interdental brush.
    Intervention Type
    Other
    Intervention Name(s)
    Gingival crevicular fluid and saliva collection
    Other Intervention Name(s)
    periodontally healthy controls, chronic periodontitis patients
    Intervention Description
    GCF collection with filter paper (Periopaper) using the intracrevicular method. Patients' mouths were rinsed with distilled water, and unstimulated salivary samples were collected by patients expectorating into disposable tubes.
    Primary Outcome Measure Information:
    Title
    Biochemical parameters (IL-32, IL-10 and THF-alpha)
    Description
    The changes in levels of IL-32 after periodontal treatment determined by ELISA. The changes in levels of IL-32 were analyzed to determine diagnostic and prognostic potential as a biomarker of periodontitis.
    Time Frame
    Baseline and 1 month after treatment
    Secondary Outcome Measure Information:
    Title
    Probing pocket depth
    Description
    The changes in probing pocket depth after periodontal treatment.Probing pocket depth was measured for determining severity of disease and clinic outcome.
    Time Frame
    Baseline and 1 month after treatment
    Title
    Probing pocket depth and clinical attachment level
    Description
    The changes in clinical attachment level after periodontal treatment. The probing depth and the distance from the gingival margin to the cemento-enamel junction are used to measurement of clinical attachment level. Clinical attachment level was measured for determining severity of disease and clinic outcome.
    Time Frame
    Baseline and 1 month after treatment
    Title
    Gingival index
    Description
    The changes in gingival index after periodontal treatment. Gingival index was recorded for classifying and evaluating (coronally) gingival inflammation.
    Time Frame
    Baseline and 1 month after treatment
    Title
    Plaque index
    Description
    The changes in plaque index after periodontal treatment. Plaque index was recorded for determining and classifying oral hygiene status.
    Time Frame
    Baseline and 1 month after treatment
    Title
    Bleeding on probing
    Description
    The changes in bleeding on probing after periodontal treatment. Bleeding on probing was recorded for classifying and evaluating (apically) gingival inflammation.
    Time Frame
    Baseline and 1 month after treatment

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    35 Years
    Maximum Age & Unit of Time
    55 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: all subjects in the study were possess of at least 20 teeth excluding third molars. Exclusion Criteria: agressive periodontitis, periapical pathologies, excessive forces including mechanical forces caused by orthodontic forces and occlusal forces; presence of systemic diseases; administration of non-steroidal and anti-inflammatory drugs or antibiotic therapies within the previous 6 months; need for antibiotic prophylaxis for dental treatment and having received non-surgical periodontal treatment within the past 6 months or surgical periodontal treatment within the past 12 months; allergy or sensitivity to any drug, pregnancy, lactation, and current and former use of tobacco.

    12. IPD Sharing Statement

    Learn more about this trial

    IL-32 Levels in Patients With Chronic Periodontitis

    We'll reach out to this number within 24 hrs